Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Operating Expenses (2023 - 2025)

Historic Operating Expenses for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $14.7 million.

  • SBC Medical Group Holdings' Operating Expenses fell 4990.48% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.9 million, marking a year-over-year decrease of 407.77%. This contributed to the annual value of $85.7 million for FY2024, which is 2866.4% up from last year.
  • Latest data reveals that SBC Medical Group Holdings reported Operating Expenses of $14.7 million as of Q3 2025, which was down 4990.48% from $15.5 million recorded in Q2 2025.
  • In the past 5 years, SBC Medical Group Holdings' Operating Expenses registered a high of $29.4 million during Q3 2024, and its lowest value of $374488.0 during Q1 2023.
  • In the last 3 years, SBC Medical Group Holdings' Operating Expenses had a median value of $14.7 million in 2025 and averaged $14.8 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first soared by 392108.75% in 2024, then tumbled by 4990.48% in 2025.
  • SBC Medical Group Holdings' Operating Expenses (Quarter) stood at $19.4 million in 2023, then skyrocketed by 50.45% to $29.2 million in 2024, then crashed by 49.48% to $14.7 million in 2025.
  • Its Operating Expenses was $14.7 million in Q3 2025, compared to $15.5 million in Q2 2025 and $13.5 million in Q1 2025.